Related Experiment Video
Updated: Jul 6, 2025

Author Spotlight: Advancing Immune Monitoring in Critical Care Patients Using Whole Blood Assays
Published on: September 20, 2024
COVID-19 mRNA Vaccination Trends Among Immunocompromised Patients
Bojan Lazarevic1, Allison R Casola1, Christopher V Chambers1
1From the Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, PA (BL); Department of Family and Community Medicine, Thomas Jefferson University, Philadelphia, PA (ARC, CVC).
COVID-19 vaccination trends in immunocompromised patients show that while most received 3+ mRNA doses, disparities exist, particularly between Black and White patients. Primary care should focus on patient-centered vaccine education to improve rates.
Area of Science:
- Immunology
- Public Health
- Epidemiology
Background:
- Immunocompromised individuals face higher risks of severe COVID-19.
- Assessing vaccination trends is crucial for public health strategies.
Purpose of the Study:
- To evaluate COVID-19 vaccination patterns among immunocompromised patients in an urban primary care setting.
- To identify trends in mRNA vaccine uptake within this vulnerable population.
Main Methods:
- Retrospective chart review of 887 immunocompromised patients from January 2021 to May 2022.
- Data collected included demographics, diagnoses, and COVID-19 mRNA vaccination status (doses and type).
- Descriptive statistics and paired t-tests were used for analysis.
Main Results:
- 62.7% of patients received 3 or more mRNA vaccine doses; 37.3% received 2 or fewer.
- Solid tumors (62.6%) and HIV/AIDS (23.8%) were common diagnoses.
- Significant disparities noted, with 42% of Black patients receiving 2 or fewer doses compared to White patients.
Conclusions:
- Despite high overall vaccination rates, significant racial disparities in COVID-19 vaccine uptake exist among immunocompromised patients.
- Primary care providers must enhance patient-centered education to address these disparities.
- Targeted outreach is essential to improve vaccination coverage in vulnerable populations.
More Related Videos
Related Concept Videos
Immunodeficiency Diseases
There are three main causes of immunodeficiency...
Vaccinations
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
Tumor Immunotherapy

